Pfizer Valuation
| PFE Stock | EUR 23.44 0.07 0.30% |
At this time, the company appears to be undervalued. Pfizer Inc holds a recent Real Value of €26.89 per share. The prevailing price of the company is €23.44. Our model determines the value of Pfizer Inc from analyzing the company fundamentals such as Operating Margin of 0.25 %, return on equity of 0.0858, and Shares Outstanding of 5.69 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Pfizer's valuation include:
Price Book 1.7039 | Enterprise Value | Enterprise Value Ebitda 13.4534 | Price Sales 2.1292 | Forward PE 9.3897 |
Undervalued
Today
Please note that Pfizer's price fluctuation is very steady at this time. Calculation of the real value of Pfizer Inc is based on 3 months time horizon. Increasing Pfizer's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pfizer stock is determined by what a typical buyer is willing to pay for full or partial control of Pfizer Inc. Since Pfizer is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pfizer Stock. However, Pfizer's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.44 | Real 26.89 | Hype 23.49 |
The real value of Pfizer Stock, also known as its intrinsic value, is the underlying worth of Pfizer Inc Company, which is reflected in its stock price. It is based on Pfizer's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pfizer's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pfizer Inc helps investors to forecast how Pfizer stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pfizer more accurately as focusing exclusively on Pfizer's fundamentals will not take into account other important factors: When choosing an evaluation method for Pfizer Inc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Pfizer Cash |
|
About Pfizer Valuation
The stock valuation mechanism determines Pfizer's current worth on a weekly basis. Our valuation model uses a comparative analysis of Pfizer. We calculate exposure to Pfizer's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pfizer's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 52.6 B | 47.6 B | |
| Pretax Profit Margin | 0.12 | 0.23 | |
| Operating Profit Margin | 0.28 | 0.21 | |
| Net Profit Margin | 0.12 | 0.14 | |
| Gross Profit Margin | 0.74 | 0.81 |
Pfizer Quarterly Retained Earnings |
|
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |